Bitcoin's price fell marginally by 0.11% to $77,674 even as trading volume surged 19.39%, indicating increased market activity without strong buying pressure. Sentiment improved but remained in the 'fear' zone, with the Fear and Greed Index at 37. Exchange reserves and net flows showed Bitcoin leaving exchanges, while active addresses increased, suggesting more network participation. Market indicators present a mixed picture, with short-term weakness but a firmer long-term outlook, highlighting cautious investor behavior amid uneven price recovery.
Bitcoin's recent price movement provides context for cryptocurrency market activity on Pluang. For readers following crypto assets, here is Pluang's market snapshot as of Nov 02, 2026 19:42 WIB: out of 50 major cryptocurrencies, 7 rose and 42 fell. Notable movers include ENJ (Enjin Coin) at Rp430 with a 1-day change of -3.22% and a typical hold time of 106 days, showing 98% sell activity; GRT (The Graph) at Rp358, down 3.08%, with 55% buy activity; and YFI (Yearn) at Rp35,420,568, down 2.95%, with 73% sell activity.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
